Everolimus and Vancomycin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Everolimus (everolimus) and Vancomycin (vancomycin). Common drug interactions include sepsis among females and drug ineffective among males.

The phase IV clinical study analyzes what interactions people have when they take Everolimus and Vancomycin. It is created by eHealthMe based on reports of 30 people who take the same drugs from the FDA, and is updated regularly.

What is Everolimus?

Everolimus has active ingredients of everolimus. eHealthMe is studying from 16,228 Everolimus users. Check the latest studies of Everolimus.

What is Vancomycin?

Vancomycin has active ingredients of vancomycin. eHealthMe is studying from 17,165 Vancomycin users. Check the latest studies of Vancomycin.



On Jul, 19, 2026

30 people who take Everolimus and Vancomycin together, and have interactions are studied.

Everolimus and Vancomycin drug interactions.

What are the common drug interactions of Everolimus and Vancomycin, by gender? *:

female:

  1. Sepsis (a severe blood infection that can lead to organ failure and death)
  2. Abdominal abscess (collection of pus in abdomen)
  3. Hyperglycaemia (high blood sugar)
  4. Pneumonia
  5. Transplant rejection (a transplant material is not worked)
  6. Cytomegalovirus infection
  7. Postoperative wound infection
  8. Urinary tract infection
  9. Cytomegalovirus viraemia (cytomegalo virus in blood stream)
  10. Lung infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung)

male:

  1. Drug ineffective
  2. Rebound effect (take-back effect)
  3. Lichenoid keratosis (a skin disorder described by rapid growing, reddish to brown, benign (noncancerous) lesion on the skin)
  4. Pneumonia fungal
  5. Stevens-johnson syndrome (an immune-complex-mediated hypersensitivity disorder. it ranges from mild skin and mucous membrane lesions to a severe)
  6. Streptococcal infection
  7. Systemic mycosis (fungal infections of the body)
  8. Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)
  9. Cytomegalovirus gastrointestinal infection (virus infection of stomach and intestine)
  10. Infection

What are the common drug interactions of Everolimus and Vancomycin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Cytomegalovirus viraemia (cytomegalo virus in blood stream)
  2. Lung infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung)
  3. Pyrexia (fever)
  4. Transplant rejection (a transplant material is not worked)

20-29:

n/a

30-39:

  1. Pneumonia
  2. Sepsis (a severe blood infection that can lead to organ failure and death)

40-49:

  1. Drug ineffective
  2. Anaemia (lack of blood)
  3. Cytomegalovirus test positive
  4. Epstein-barr virus antibody positive
  5. Escherichia infection (bacterial infection by escherichia coli)
  6. Febrile neutropenia (fever with reduced white blood cells)
  7. Neutropenia (an abnormally low number of neutrophils)
  8. Pleural effusion (water on the lungs)
  9. Post transplant lymphoproliferative disorder
  10. Staphylococcal infection (an infection with staphylococcus bacteria)

50-59:

  1. Sepsis (a severe blood infection that can lead to organ failure and death)
  2. Abdominal abscess (collection of pus in abdomen)
  3. Hyperglycaemia (high blood sugar)
  4. Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood)
  5. Pneumonia
  6. Wernicke's encephalopathy (ocular disturbances, changes in mental state, unsteady stance and gait due to deficiency of vit.b1)
  7. Drug ineffective
  8. Erythrophagocytosis
  9. Post transplant lymphoproliferative disorder
  10. Cytomegalovirus gastrointestinal infection (virus infection of stomach and intestine)

60+:

  1. Drug ineffective
  2. Rebound effect (take-back effect)
  3. Systemic mycosis (fungal infections of the body)
  4. Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)
  5. Transplant rejection (a transplant material is not worked)
  6. Alpha haemolytic streptococcal infection (infections with alpha-haemolytic strep bacteria are common; many strains live naturally in humans)
  7. Clostridial infection (infectious conditions by clostridium bacteria)
  8. Enterococcal infection
  9. Hepatotoxicity (chemical-driven liver damage)
  10. Lichenoid keratosis (a skin disorder described by rapid growing, reddish to brown, benign (noncancerous) lesion on the skin)

What are the existing conditions these people have? *

  1. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 7 people, 23.33%
  2. Acute Respiratory Failure: 4 people, 13.33%
  3. Anaemia (lack of blood): 4 people, 13.33%
  4. Depression: 4 people, 13.33%
  5. Enterococcal Infection: 4 people, 13.33%
  6. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 13.33%
  7. Hepatic Encephalopathy (spectrum of neuropsychiatric abnormalities in patients with liver failure): 4 people, 13.33%
  8. High Blood Pressure: 4 people, 13.33%
  9. Hyperglycemia (high blood sugar): 4 people, 13.33%
  10. Hypocalcaemia (levels of calcium in blood serum are abnormally low): 4 people, 13.33%

* Approximation only. Some reports may have incomplete information.

Do you take Everolimus and Vancomycin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Everolimus and Vancomycin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Everolimus:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Vancomycin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Everolimus and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Vancomycin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on everolimus and vancomycin (the active ingredients of Everolimus and Vancomycin, respectively), and Everolimus and Vancomycin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: